Hi M@g,
I think @Davisite mentioned not so long ago that a SH gave some outstanding advice that would Speed up the process, save money and get onto a quicker pathway. @Biotargo is one standout poster/SH who knows there stuff that may have put DT on the right path. You can check the conversation if you go back a couple of months in August. If a path had been set before this knowledge had come to the for it would have been too late as the company direction would have already taken place. All IMO. Might have been a different SH and I could be off track.
Regards.
HeyLine
Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-228
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.070(4.32%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.65 | $1.54 | $145.6K | 91.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5700 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 296 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |